HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A study of biological behavior based on the expression of a proliferating antigen in neuroendocrine tumors of the digestive system.

Abstract
The expression of a proliferating antigen by Ki-67 immunohistochemistry was evaluated in 32 gastrointestinal carcinoids and in 5 pancreatic islet cell tumors. In the tissue sections the number of labelled nuclei was calculated per tumor area. The tumors were classified as low proliferating (less than 0.3 labelled cells/mm2), medium proliferating (0.3-1 labelled cells/mm2), and high proliferating (greater than 1 labelled cell/mm2). In 26 tumors obtained from patients receiving antitumor therapy (alpha-interferon) the proliferative activity was decreased. In treated midgut carcinoids the proliferative activity in metastatic tissue was significantly reduced (p less than 0.05). Though not statistically significant, primary midgut carcinoids collected from untreated patients displayed a lower proliferative activity than liver metastases. A survival analysis revealed that patients with tumors displaying low proliferative activity had a better survival than those with high proliferative activity (p less than 0.05). Single cell cytofluorometric DNA analyses showed regular diploid stem cell lines in the majority of tumors from untreated patients (9/11 cases). No correlation was found between the calculated proliferative activity and the DNA profile. The obtained results indicate that the expression of a proliferation antigen by Ki-67 immunohistochemistry can be used to evaluate the biological behavior of neuroendocrine tumors of the digestive system and predict survival.
AuthorsA Chaudhry, K Oberg, E Wilander
JournalTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine (Tumour Biol) Vol. 13 Issue 1-2 Pg. 27-35 ( 1992) ISSN: 1010-4283 [Print] Netherlands
PMID1317054 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interferon-alpha
  • Ki-67 Antigen
  • Nuclear Proteins
Topics
  • Adenoma, Islet Cell (immunology, physiopathology)
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoid Tumor (immunology)
  • Cell Division (drug effects, immunology)
  • Gastrointestinal Neoplasms (immunology, physiopathology)
  • Humans
  • Interferon-alpha (pharmacology)
  • Ki-67 Antigen
  • Middle Aged
  • Nuclear Proteins (immunology)
  • Pancreatic Neoplasms (immunology)
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: